News
This follows a major move by the US Food and Drug Administration (FDA) in January, under former President Joe Biden, to ban red dye No. 3 in food, drinks and some drugs. That action came more than 30 ...
Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.
All the scientists were fired from the only STI lab in the US that tested how well antibiotics were working against drug-resistant gonorrhea strains.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to BA-102 for the treatment of Phelan-McDermid syndrome, a rare neurodevelopmental disorder linked to autism.
The plan would cut tens of billions of dollars from federal health spending and move many already existing agencies into a new department called the Administration for a Healthy America.
These HHS staffing cuts, 20,000, obviously they are completely nuts,” Wendell Primus, who worked at the ASPE during the Clinton administration.
When leveraged to their appropriate context and strengths, under the care of an oncologist, cancer-related apps can actually strengthen the bond with the physician and care team, while empowering the ...
After 3 initial monthly injections, current dosing intervals range from every 8 to 16 weeks in patients with wAMD and DME and every 8 to 12 weeks in patients with DR.
Cytisinicline treatment significantly increased the odds of smoking cessation and reduced nicotine cravings compared with placebo. Cytisinicline significantly increased the likelihood of quitting and ...
Enhertu (fam-trastuzumab deruxtecan-nxki) is currently indicated as a second-line therapy for HER2-positive metastatic breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results